Chen, R., & Chen, B. (2015). Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma. Drug Des Devel Ther.
Citação norma ChicagoChen, Runzhe, and Baoan Chen. "Brentuximab Vedotin for Relapsed or Refractory Hodgkin’s Lymphoma." Drug Des Devel Ther 2015.
MLA citiranjeChen, Runzhe, and Baoan Chen. "Brentuximab Vedotin for Relapsed or Refractory Hodgkin’s Lymphoma." Drug Des Devel Ther 2015.
Opozorilo: Ti citati niso vedno 100% točni.